<p>Alignment Healthcare（纳斯达克：ALHC - 获取免费报告）在周三发布的研究报告中，摩根大通的股票研究人员将其目标价从 20.00 美元上调至 23.00 美元。该公司目前对该股票的评级为 “超配”。摩根大通的目标价表明，相较于公司当前价格，存在 12.03% 的潜在上涨空间。</p>
<p>ALHC 已经成为其他几份研究报告的主题。高盛集团在 11 月 3 日的研究报告中重申了对 Alignment Healthcare 的 “买入” 评级，并给出了 22.00 美元的目标价。Weiss Ratings 在 10 月 8 日的报告中重申了对 Alignment Healthcare 的 “卖出（d-）” 评级。KeyCorp 在 11 月 24 日的研究报告中重申了对 Alignment Healthcare 的 “超配” 评级。巴克莱在 10 月 31 日的研究报告中将 Alignment Healthcare 的目标价从 13.00 美元上调至 18.00 美元，并给予该公司 “等权重” 评级。最后，华尔街 Zen 在 11 月 8 日的报告中将 Alignment Healthcare 的评级从 “持有” 上调至 “买入”。一位股票研究分析师给予该股票 “强烈买入” 评级，八位分析师给予 “买入” 评级，三位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 20.35 美元。</p>
<p>获取 <strong>Alignment Healthcare</strong> 警报：</p>
<p><strong>阅读我们对 ALHC 的最新分析</strong></p>
<h2>Alignment Healthcare 股票上涨 2.5%</h2>
<p>在周三的交易中，ALHC 股票上涨 0.50 美元，达到 20.53 美元。该公司股票的交易量为 1,002,049 股，而其平均交易量为 3,029,211 股。该公司的市值为 41.1 亿美元，市盈率为-171.06，贝塔值为 1.16。Alignment Healthcare 的 1 年最低价为 10.18 美元，1 年最高价为 21.06 美元。该公司的速动比率为 1.61，流动比率为 1.61，债务与股本比率为 1.99。该公司的 50 日简单移动平均线为 17.77 美元，200 日简单移动平均线为 15.91 美元。</p>
<p>Alignment Healthcare（纳斯达克：ALHC - 获取免费报告）最后一次发布财报是在 10 月 30 日，报告显示该公司季度每股收益为 0.02 美元，超出分析师共识预期的-0.01 美元，超出幅度为 0.03 美元。Alignment Healthcare 的股本回报率为-16.23%，净利润率为-0.57%。该公司在本季度的收入为 9.937 亿美元，而分析师预期为 9.809 亿美元。在去年同期，该公司的每股收益为-0.14 美元。Alignment Healthcare 的收入同比增长 43.5%。卖方分析师预计 Alignment Healthcare 在本年度的每股收益为-0.69 美元。</p>
<h2>Alignment Healthcare 的内部活动</h2>
<p>在相关消息中，首席执行官 John E. Kao 在 12 月 10 日的交易中出售了 180,000 股公司的股票，交易价格为 19.02 美元，总价值为 3,423,600.00 美元。交易完成后，首席执行官直接持有公司 2,346,726 股，价值 44,634,728.52 美元。此次交易使其持股减少了 7.12%。该交易已在向 SEC 提交的文件中披露，相关文件可在 SEC 网站上查阅。此外，首席运营官 Sebastian Burzacchi 在 12 月 10 日的交易中出售了 12,585 股公司的股票，交易价格为 19.26 美元，总交易额为 242,387.10 美元。交易完成后，首席运营官持有 237,793 股公司的股票，价值约为 4,579,893.18 美元。此次交易使其持股减少了 5.03%。该销售的披露信息可在 SEC 文件中找到。内部人士在过去三个月内出售了 842,157 股公司股票，价值 15,187,475 美元。公司内部人士持有公司股票的 6.60%。</p>
<h2>Alignment Healthcare 的机构交易</h2>
<p>最近，一些机构投资者和对冲基金已修改其对 ALHC 的持股。Wellington Management Group LLP 在第三季度将其在 Alignment Healthcare 的持股增加了 167.3%。Wellington Management Group LLP 现在拥有 11,089,727 股公司股票，价值 193,516,000 美元，在上个季度又购买了 6,940,277 股。Invesco Ltd.在第二季度将其在 Alignment Healthcare 的持股增加了 122.3%。Invesco Ltd.现在拥有 4,170,529 股公司股票，价值 58,387,000 美元，在上个季度又收购了 2,294,739 股。Vanguard Group Inc.在第一季度将其在 Alignment Healthcare 的持股增加了 13.2%。Vanguard Group Inc.现在拥有 11,113,896 股公司股票，价值 206,941,000 美元，在上个季度又收购了 1,295,825 股。Marshall Wace LLP 在第二季度将其在 Alignment Healthcare 的持股增加了 173.3%。Marshall Wace LLP 现在拥有 2,039,714 股公司股票，价值 28,556,000 美元，在上个季度又购买了 1,293,416 股。最后，Voya Investment Management LLC 在第三季度将其在 Alignment Healthcare 的持股增加了 61.0%。Voya Investment Management LLC 现在拥有 3,196,297 股公司股票，价值 55,775,000 美元，在上个季度又购买了 1,210,930 股。对冲基金和其他机构投资者持有公司股票的 86.19%。</p>
<h2>Alignment Healthcare 公司简介</h2>
<p>（获取免费报告）</p>
<p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国老年人提供以消费者为中心的医疗保健平台。它通过医疗保险优势计划提供定制的医疗保健，以满足多样化老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
<h2>了解更多</h2>
<ul>
<li>我们更看好的五只股票，胜过 Alignment Healthcare</li>
<li>外汇是什么，如何运作？</li>
<li>特斯拉被高估了吗？可能是便宜货的两个理由</li>
<li>如何绘制斐波那契价格拐点水平</li>
<li>这两只股票如何赢得 2025 年的人工智能竞赛——2026 年又将如何</li>
<li>百分比涨幅告诉投资者什么，以及为什么它们并不能讲述全部故事</li>
<li>英特尔以低价收购人工智能技术</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资$1,000 在 Alignment Healthcare 吗？</h2>
<p>在你考虑 Alignment Healthcare 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Alignment Healthcare 并不在名单上。</p>
<p>虽然 Alignment Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

ALHC

<p>摩根大通将 Alignment Healthcare（NASDAQ:ALHC）的目标股价从 20.00 美元上调至 23.00 美元，维持 “增持” 评级，暗示潜在上涨幅度为 12.03%。该股票的共识评级为 “适度买入”，目标价格为 20.35 美元。近期内部交易中，首席执行官 John E. Kao 和首席运营官 Sebastian Burzacchi 进行了大量股票出售。机构投资者如 Wellington Management 和 Invesco 已增加在该公司的持股</p>

<p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) had its price target upped by equities researchers at JPMorgan Chase &amp; Co. from $20.00 to $23.00 in a research note issued on Wednesday,Benzinga reports. The firm presently has an &#34;overweight&#34; rating on the stock. JPMorgan Chase &amp; Co.'s target price indicates a potential upside of 12.03% from the company's current price.</p>
<div class="lb-trans"><p>Alignment Healthcare（纳斯达克：ALHC - 获取免费报告）在周三发布的研究报告中，摩根大通的股票研究人员将其目标价从 20.00 美元上调至 23.00 美元。该公司目前对该股票的评级为 “超配”。摩根大通的目标价表明，相较于公司当前价格，存在 12.03% 的潜在上涨空间。</p>
</div><p>ALHC has been the topic of several other research reports. The Goldman Sachs Group reiterated a &#34;buy&#34; rating and issued a $22.00 target price on shares of Alignment Healthcare in a research note on Monday, November 3rd. Weiss Ratings restated a &#34;sell (d-)&#34; rating on shares of Alignment Healthcare in a report on Wednesday, October 8th. KeyCorp reiterated an &#34;overweight&#34; rating on shares of Alignment Healthcare in a research note on Monday, November 24th. Barclays increased their target price on shares of Alignment Healthcare from $13.00 to $18.00 and gave the company an &#34;equal weight&#34; rating in a research report on Friday, October 31st. Finally, Wall Street Zen raised shares of Alignment Healthcare from a &#34;hold&#34; rating to a &#34;buy&#34; rating in a report on Saturday, November 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $20.35.</p>
<div class="lb-trans"><p>ALHC 已经成为其他几份研究报告的主题。高盛集团在 11 月 3 日的研究报告中重申了对 Alignment Healthcare 的 “买入” 评级，并给出了 22.00 美元的目标价。Weiss Ratings 在 10 月 8 日的报告中重申了对 Alignment Healthcare 的 “卖出（d-）” 评级。KeyCorp 在 11 月 24 日的研究报告中重申了对 Alignment Healthcare 的 “超配” 评级。巴克莱在 10 月 31 日的研究报告中将 Alignment Healthcare 的目标价从 13.00 美元上调至 18.00 美元，并给予该公司 “等权重” 评级。最后，华尔街 Zen 在 11 月 8 日的报告中将 Alignment Healthcare 的评级从 “持有” 上调至 “买入”。一位股票研究分析师给予该股票 “强烈买入” 评级，八位分析师给予 “买入” 评级，三位分析师给予 “持有” 评级，一位分析师给予 “卖出” 评级。根据 MarketBeat.com 的数据，该股票目前的共识评级为 “适度买入”，共识目标价为 20.35 美元。</p>
</div><p>Get <strong>Alignment Healthcare</strong> alerts:</p>
<div class="lb-trans"><p>获取 <strong>Alignment Healthcare</strong> 警报：</p>
</div><p><strong>Read Our Latest Analysis on ALHC</strong></p>
<div class="lb-trans"><p><strong>阅读我们对 ALHC 的最新分析</strong></p>
</div><h2>Alignment Healthcare Stock Up 2.5%</h2>
<div class="lb-trans"><h2>Alignment Healthcare 股票上涨 2.5%</h2>
</div><p>ALHC stock traded up $0.50 during trading on Wednesday, hitting $20.53. 1,002,049 shares of the company's stock traded hands, compared to its average volume of 3,029,211. The firm has a market capitalization of $4.11 billion, a P/E ratio of -171.06 and a beta of 1.16. Alignment Healthcare has a 1 year low of $10.18 and a 1 year high of $21.06. The company has a quick ratio of 1.61, a current ratio of 1.61 and a debt-to-equity ratio of 1.99. The business has a fifty day simple moving average of $17.77 and a two-hundred day simple moving average of $15.91.</p>
<div class="lb-trans"><p>在周三的交易中，ALHC 股票上涨 0.50 美元，达到 20.53 美元。该公司股票的交易量为 1,002,049 股，而其平均交易量为 3,029,211 股。该公司的市值为 41.1 亿美元，市盈率为-171.06，贝塔值为 1.16。Alignment Healthcare 的 1 年最低价为 10.18 美元，1 年最高价为 21.06 美元。该公司的速动比率为 1.61，流动比率为 1.61，债务与股本比率为 1.99。该公司的 50 日简单移动平均线为 17.77 美元，200 日简单移动平均线为 15.91 美元。</p>
</div><p>Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its earnings results on Thursday, October 30th. The company reported $0.02 earnings per share for the quarter, topping analysts' consensus estimates of ($0.01) by $0.03. Alignment Healthcare had a negative return on equity of 16.23% and a negative net margin of 0.57%.The company had revenue of $993.70 million during the quarter, compared to analyst estimates of $980.90 million. During the same quarter in the prior year, the business earned ($0.14) earnings per share. Alignment Healthcare's revenue was up 43.5% on a year-over-year basis. Sell-side analysts anticipate that Alignment Healthcare will post -0.69 EPS for the current year.</p>
<div class="lb-trans"><p>Alignment Healthcare（纳斯达克：ALHC - 获取免费报告）最后一次发布财报是在 10 月 30 日，报告显示该公司季度每股收益为 0.02 美元，超出分析师共识预期的-0.01 美元，超出幅度为 0.03 美元。Alignment Healthcare 的股本回报率为-16.23%，净利润率为-0.57%。该公司在本季度的收入为 9.937 亿美元，而分析师预期为 9.809 亿美元。在去年同期，该公司的每股收益为-0.14 美元。Alignment Healthcare 的收入同比增长 43.5%。卖方分析师预计 Alignment Healthcare 在本年度的每股收益为-0.69 美元。</p>
</div><h2>Insider Activity at Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的内部活动</h2>
</div><p>In related news, CEO John E. Kao sold 180,000 shares of the business's stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $19.02, for a total value of $3,423,600.00. Following the completion of the transaction, the chief executive officer directly owned 2,346,726 shares in the company, valued at $44,634,728.52. The trade was a 7.12% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, COO Sebastian Burzacchi sold 12,585 shares of the company's stock in a transaction dated Wednesday, December 10th. The stock was sold at an average price of $19.26, for a total transaction of $242,387.10. Following the completion of the transaction, the chief operating officer owned 237,793 shares of the company's stock, valued at approximately $4,579,893.18. This trade represents a 5.03% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 842,157 shares of company stock worth $15,187,475 in the last three months. Company insiders own 6.60% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 John E. Kao 在 12 月 10 日的交易中出售了 180,000 股公司的股票，交易价格为 19.02 美元，总价值为 3,423,600.00 美元。交易完成后，首席执行官直接持有公司 2,346,726 股，价值 44,634,728.52 美元。此次交易使其持股减少了 7.12%。该交易已在向 SEC 提交的文件中披露，相关文件可在 SEC 网站上查阅。此外，首席运营官 Sebastian Burzacchi 在 12 月 10 日的交易中出售了 12,585 股公司的股票，交易价格为 19.26 美元，总交易额为 242,387.10 美元。交易完成后，首席运营官持有 237,793 股公司的股票，价值约为 4,579,893.18 美元。此次交易使其持股减少了 5.03%。该销售的披露信息可在 SEC 文件中找到。内部人士在过去三个月内出售了 842,157 股公司股票，价值 15,187,475 美元。公司内部人士持有公司股票的 6.60%。</p>
</div><h2>Institutional Trading of Alignment Healthcare</h2>
<div class="lb-trans"><h2>Alignment Healthcare 的机构交易</h2>
</div><p>A number of institutional investors and hedge funds have recently modified their holdings of ALHC. Wellington Management Group LLP increased its stake in Alignment Healthcare by 167.3% during the 3rd quarter. Wellington Management Group LLP now owns 11,089,727 shares of the company's stock worth $193,516,000 after buying an additional 6,940,277 shares in the last quarter. Invesco Ltd. boosted its stake in shares of Alignment Healthcare by 122.3% in the second quarter. Invesco Ltd. now owns 4,170,529 shares of the company's stock worth $58,387,000 after acquiring an additional 2,294,739 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of Alignment Healthcare by 13.2% in the first quarter. Vanguard Group Inc. now owns 11,113,896 shares of the company's stock worth $206,941,000 after acquiring an additional 1,295,825 shares during the last quarter. Marshall Wace LLP increased its position in shares of Alignment Healthcare by 173.3% during the second quarter. Marshall Wace LLP now owns 2,039,714 shares of the company's stock worth $28,556,000 after purchasing an additional 1,293,416 shares in the last quarter. Finally, Voya Investment Management LLC raised its stake in Alignment Healthcare by 61.0% in the 3rd quarter. Voya Investment Management LLC now owns 3,196,297 shares of the company's stock valued at $55,775,000 after purchasing an additional 1,210,930 shares during the last quarter. Hedge funds and other institutional investors own 86.19% of the company's stock.</p>
<div class="lb-trans"><p>最近，一些机构投资者和对冲基金已修改其对 ALHC 的持股。Wellington Management Group LLP 在第三季度将其在 Alignment Healthcare 的持股增加了 167.3%。Wellington Management Group LLP 现在拥有 11,089,727 股公司股票，价值 193,516,000 美元，在上个季度又购买了 6,940,277 股。Invesco Ltd.在第二季度将其在 Alignment Healthcare 的持股增加了 122.3%。Invesco Ltd.现在拥有 4,170,529 股公司股票，价值 58,387,000 美元，在上个季度又收购了 2,294,739 股。Vanguard Group Inc.在第一季度将其在 Alignment Healthcare 的持股增加了 13.2%。Vanguard Group Inc.现在拥有 11,113,896 股公司股票，价值 206,941,000 美元，在上个季度又收购了 1,295,825 股。Marshall Wace LLP 在第二季度将其在 Alignment Healthcare 的持股增加了 173.3%。Marshall Wace LLP 现在拥有 2,039,714 股公司股票，价值 28,556,000 美元，在上个季度又购买了 1,293,416 股。最后，Voya Investment Management LLC 在第三季度将其在 Alignment Healthcare 的持股增加了 61.0%。Voya Investment Management LLC 现在拥有 3,196,297 股公司股票，价值 55,775,000 美元，在上个季度又购买了 1,210,930 股。对冲基金和其他机构投资者持有公司股票的 86.19%。</p>
</div><h2>Alignment Healthcare Company Profile</h2>
<div class="lb-trans"><h2>Alignment Healthcare 公司简介</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.</p>
<div class="lb-trans"><p>Alignment Healthcare, Inc.是一家技术驱动的医疗保险优势公司，为美国老年人提供以消费者为中心的医疗保健平台。它通过医疗保险优势计划提供定制的医疗保健，以满足多样化老年人的需求。该公司成立于 2013 年，总部位于加利福尼亚州橙县。</p>
</div><h2>Read More</h2>
<div class="lb-trans"><h2>了解更多</h2>
</div><ul>
<li>Five stocks we like better than Alignment Healthcare</li>
<li>What is Forex and How Does it Work?</li>
<li>Is Tesla Overvalued? 2 Reasons It Might Be a Bargain</li>
<li>How to Plot Fibonacci Price Inflection Levels</li>
<li>How These 2 Stocks Won 2025's AI Race—And What's In Store for 2026</li>
<li>What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story</li>
<li>Intel Snaps Up AI Tech for Pennies on the Dollar</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票，胜过 Alignment Healthcare</li>
<li>外汇是什么，如何运作？</li>
<li>特斯拉被高估了吗？可能是便宜货的两个理由</li>
<li>如何绘制斐波那契价格拐点水平</li>
<li>这两只股票如何赢得 2025 年的人工智能竞赛——2026 年又将如何</li>
<li>百分比涨幅告诉投资者什么，以及为什么它们并不能讲述全部故事</li>
<li>英特尔以低价收购人工智能技术</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9QUxIQw" alt="" original-src="https://www.marketbeat.com/scripts/RatingsAndPriceTargetChart.ashx?Prefix=NASDAQ&amp;Symbol=ALHC"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Alignment Healthcare Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资$1,000 在 Alignment Healthcare 吗？</h2>
</div><p>Before you consider Alignment Healthcare, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 Alignment Healthcare 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄建议客户现在购买的股票，以便在更广泛的市场注意到之前……而 Alignment Healthcare 并不在名单上。</p>
</div><p>While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Alignment Healthcare 目前在分析师中获得了中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

摩根大通公司将 Alignment Healthcare（纳斯达克代码：ALHC）的目标股价上调至 23.00 美元